I feel a little funny barging in like this,
but I've been lurking and here are my two
cents worth of ideas:
ARIA, could be a good daytrade Monday--the May 18
issue of Barron's refers to Sugen and Ligand when
it mentioned signal transduction. SUGN has been
getting all the exposure because of Entremed lately,
but eventually these journalists will start throwing
more names around. If all the signal transduction
companies pop Monday, maybe Ariad will too. I'll be
watching from the sidelines, not that it matters, but
I'm in the middle of a self-imposed trading break
(eeek down ten percent on my current holds, first time
I've been underwater this year...
Second idea is RGEN. I personally traded Repligen
(not regn) the day Entremed popped on the run from 2
to 3 and now am back in that to hold it awhile with
a basis of 2.
Third idea, NTII. This is the one I'm banking on
right now. You might want to watch it and see if it
goes back down around 5/8ths, it ran up on recent
news and has been sagging back lately. I thought
the conference call was good (newbie to calls so
don't know for sure if it really was a positive
call). Anyway, sometime in the next six months it
looks like Neurobiological Tech will do a deal with
a big pharma company on Mematine, a potential dementia
or Alzheimers therapy (actually has potential as
a neuro-protectant agent, so my guess is that maybe
it could slow the progress of Alzheimers). This
compound is only in phaseIIb, but I gathered from
reading biotech posts on SI that sometimes you can
have good luck getting in around phaseII and getting
out if it looks like phaseIII are a good possiblility.
Actually, now that I think about it, maybe the neuro-
protectant they have is Xerecept, for which they
have orphan drug status and more grant money potential.
Aww hell, do your own reading of the news items off
of yahoo, I can hardly read my notes.
I have no training in biotech at all
--that is your warning, hehe.
I also hold TGEN and IFSC, both bot recently for
some really speculative thoughts I had.
Do I know what the hell I am talking about?
Probably not, but I've had good luck trading
so far this year, and I see this market rotating
into biotech now, waaay too much cash out there
with nothing to do, just wait til those yups start
cashing out of Dell and Microsoft and get into
the puny 100B market cap sector that is biotech,
yippie! |
